Little is known about the biological and structural features that govern the isoform selectivity for class I histone deacetylases (HDACs) over HDAC6. In addition to that for known inhibitors, like benzamides, psammaplin A, and cyclodepsipeptide-derived thiols, selectivity was also observed for naturally occurring cyclopeptide HDAC inhibitors with an aliphatic flexible linker and ketonelike zinc-binding group (ZBG). The present study reports that this isoform selectivity is mainly due to the linker and ZBG, as replacement of the cyclopeptide cap region by a simple aniline retained class I HDAC isoform selectivity toward HDAC6 in enzymatic assays. The best cyclopeptide-free analogues preserved efficacy against Plasmodium falciparum and cancer...
Several oxime containing molecules, characterized by a SAEA-like structure, were explored to select ...
Several oxime containing molecules, characterized by a SAHA-like structure, were explored to select ...
International audienceA series of hydroxamic acids linked by different lengths to a chiral imidazo-k...
Little is known about the biological and structural features that govern the isoform selectivity for...
Histone Deacetylases (HDACs) are among the most attractive and interesting targets in anticancer dru...
Histone deacetylase (HDAC) proteins have become an important target for the treatment of several dis...
Herein we report the structure-activity and structure-physicochemical property relationships of a se...
Reversible lysine acetylation serves as a critical regulatory pathway for diverse cellular processes...
Histone deacetylase 6 (HDAC6) is a crucial regulator in various cancer types and several non-oncolog...
Histone deacetylase 6 (HDAC6) is an established drug target for cancer treatment. Inhibitors of HDAC...
Zinc binding groups (ZBGs) play a crucial role in targeting histone deacetylase inhibitors (HDACIs) ...
In humans, the zinc-dependent histone deacetylases (HDACs) are a family of 11 nonredundant isoforms ...
Histone Deacetylases are considered promising targets for cancer epigenetic therapy, and small molec...
The application of class I HDAC inhibitors as cancer therapies is well established, but more recentl...
The high structural homology of histone deacetylases 6 and 8 (HDAC6/8) poses a challenge in achievin...
Several oxime containing molecules, characterized by a SAEA-like structure, were explored to select ...
Several oxime containing molecules, characterized by a SAHA-like structure, were explored to select ...
International audienceA series of hydroxamic acids linked by different lengths to a chiral imidazo-k...
Little is known about the biological and structural features that govern the isoform selectivity for...
Histone Deacetylases (HDACs) are among the most attractive and interesting targets in anticancer dru...
Histone deacetylase (HDAC) proteins have become an important target for the treatment of several dis...
Herein we report the structure-activity and structure-physicochemical property relationships of a se...
Reversible lysine acetylation serves as a critical regulatory pathway for diverse cellular processes...
Histone deacetylase 6 (HDAC6) is a crucial regulator in various cancer types and several non-oncolog...
Histone deacetylase 6 (HDAC6) is an established drug target for cancer treatment. Inhibitors of HDAC...
Zinc binding groups (ZBGs) play a crucial role in targeting histone deacetylase inhibitors (HDACIs) ...
In humans, the zinc-dependent histone deacetylases (HDACs) are a family of 11 nonredundant isoforms ...
Histone Deacetylases are considered promising targets for cancer epigenetic therapy, and small molec...
The application of class I HDAC inhibitors as cancer therapies is well established, but more recentl...
The high structural homology of histone deacetylases 6 and 8 (HDAC6/8) poses a challenge in achievin...
Several oxime containing molecules, characterized by a SAEA-like structure, were explored to select ...
Several oxime containing molecules, characterized by a SAHA-like structure, were explored to select ...
International audienceA series of hydroxamic acids linked by different lengths to a chiral imidazo-k...